Retroperitoneal and mesenteric liposarcomas.
Siew, Caroline C H Apte, Sameer S Baia, Marco Gyorki, David E Ford, Samuel van Houdt, Winan J
Siew, Caroline C H
Apte, Sameer S
Baia, Marco
Gyorki, David E
Ford, Samuel
van Houdt, Winan J
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2022-07
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
Retroperitoneal liposarcomas are a rare entity and are comprised mostly of the well-differentiated and dedifferentiated subtypes. Eight-year survival ranges from 30% to 80% depending on histologic subtype and grade. Surgery is the cornerstone of treatment and compartment resection is the current standard. Mesenteric liposarcomas are extremely rare and comprise more high-grade lesions, with poorer prognosis of 50% 5-year overall survival. They are managed with a similar aggressive surgical approach. This review presents the current management of retroperitoneal and mesenteric liposarcomas.
Citation
Siew CCH, Apte SS, Baia M, Gyorki DE, Ford S, van Houdt WJ. Retroperitoneal and Mesenteric Liposarcomas. Surg Oncol Clin N Am. 2022 Jul;31(3):399-417. doi: 10.1016/j.soc.2022.03.005
Type
Article